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OBJECTIVES: Poststroke shoulder pain occurs very frequently and compromises function and quality of life.
Because treatment depends on a multidisciplinary approach, it is desirable to optimize effectiveness. Myofascial
pain syndrome is defined by the presence of trigger points that can also be found in spastic stroke patients. The
aim of this study was to evaluate the frequency of myofascial pain in the shoulder girdle muscles in patients
with poststroke shoulder pain and to document the clinical and functional results obtained with specific treat-
ment for this condition.
METHODS: Spastic stroke hemiplegic patients undergoing rehabilitation at the Rehabilitation Center of the
Hospital das Clı´nicas of the Ribeira˜o Preto Medical School of the University of Sa˜o Paulo were evaluated regard-
ing the intensity and characteristics of shoulder pain, previous therapeutic interventions, shoulder goniometry
and the presence of trigger points. Patients underwent trigger point blockade by intramuscular infiltration of
1% lidocaine. The evaluation and treatment procedures were repeated in the subsequent 3 weeks as long as the
pain intensity was greater than 5 on a visual analog scale (VAS). In the fourth week, the evaluation procedures
were repeated. Patients who were in a multiprofessional rehabilitation program were instructed to continue
the treatment, and the others received complementary therapeutic advice if necessary to initiate it. The evalua-
tions were performed at 0, 1, and 3 weeks and after 4 months.
RESULTS: Twenty-one patients (13 men; age=67.8±10.2 years; right hemiparesis: 11) participated in the study,
and there was a reduction in pain assessed by VAS from baseline (7.6±2.7) to the first week (5.8±3.6; po0.05)
through the end of the third week (5.2±3.5; po0.05), but not at the end of four months (6.6±2.9; p=0.11).
Good responders had significantly lower pain levels after the third week and presented with a larger range of
motion for passive abduction by the end of 4 months. These results demonstrate that the myofascial component
of pain should be considered in poststroke shoulder pain and that its treatment may be a pathway for the rapid
and long-lasting relief of symptoms.
CONCLUSION: Trigger point blockade with lidocaine can reduce pain perception in spastic hemiplegic shoulder
in as much as 50% of stroke survivors for four months.
KEYWORDS: Painful Shoulder; Hemiplegia; Treatment; Myofascial Pain Syndrome; Pain; Functioning.
’ INTRODUCTION
Poststroke shoulder pain (PSSP) is defined by musculos-
keletal pain in the weakened shoulder of hemiplegic indivi-
duals due to stroke. The clinical features of PSSP vary from
mild discomfort to disabling pain, often acting as a precursor
factor for secondary anatomical deformities. Pain is most
often referred to as heavy, continuous or triggered by passive
or active mobilization, is associated with decreased range of
motion and increased disability in activities of daily living
or care, and can lead to immobility and progressively
worsening function. Thus, PSSP interferes with adequate
participation in rehabilitation programs (1,2) and is therefore
associated with worse prognoses (3-5) and more hospital
admissions, where such contexts apply (6). The reported
prevalence of PSSP varies in the literature between 16% and
84% (1,5), with significant symptomatology in approximately
70% of cases (1). PSSP usually develops in patients with little
or no voluntary movement of the affected upper limb as well
as in poorly positioned ones (7). PSSP has been considered an
additional risk factor for the onset of depressive disorders,
interfering even more in the individual’s functioning (3,4).
The etiology of PSSP is still controversial and multifactorial
(7), but several factors have been described as causes, such as
rotator cuff lesions, glenohumeral dislocation, hand shoulder
syndrome, myofascial pain syndrome (MPS), spasticity and
contractures, and adhesive capsulitis, among other soft tissue
disorders (1,5). Brachial plexus neuropathy secondary to
traction also plays a role in the development of unusual
patterns of impaired motor function or spasticity or severe
focal atrophy. Central pain should also be considered (7,8).
Usually, the condition develops 2-3 months after the stroke,
in some cases as early as 2 weeks (2), but usually in the firstDOI: 10.6061/clinics/2019/e905
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6 months (7). Adequate management of PSSP allows the
patient to fully participate in the rehabilitation program in
addition to promoting better functional outcomes (2). The ideal
treatment should start with adequate prevention immediately
after the stroke because once the patient presents with pain,
secondary anxiety and overprotection can hinder an effective
approach (5). The management of PSSP is difficult, and the
clinical picture, as well as the responses to the therapies used,
is varied, creating a context in which multidisciplinary app-
roaches tend to present a better result. There is little evidence to
date regarding the available treatments for this condition.
MPS is a regional pain condition associated with the pre-
sence of trigger points (TP). Trigger points are regions of the
body surface over the muscles that are painful to palpation
and reproduce the patients’ complaints, and when properly
treated, lead to the improvement of symptoms (9). In these
regions, tense muscle bands identified on palpation are asso-
ciated with a reduced range of motion and sometimes exhibit
a brief contraction to the digital motor stimulus or the infil-
tration needle; this contraction is called a ‘twitch’ and denotes
the precise identification of the TP. MPS usually occurs in
unconditioned muscles, under high tension conditions or after
direct local trauma or strains (10). Treatment of this musculo-
skeletal condition includes the deactivation of TP by procedures
such as dry needling or 1% lidocaine infiltration. Additionally,
physical resources such as heat and electrotherapy, exercises
for the balance of periarticular forces, massage therapy or
acupuncture can be used. It is the experience of our group
that MPS is a frequent etiology of pain in these cases; thus,
the inactivation of TPs in the shoulder muscle girdle can
improve PSSP, passive functioning and mobility (11).
Objectives
This study aimed to evaluate whether TP blockade is
effective in reducing pain assessed by VAS and improving
shoulder goniometry in spastic subjects with PSSP.
’ METHODS
This paper describes a series of twenty-one patients with
stable cerebral lesions who were enrolled from an outpatient
rehabilitation clinic at the Rehabilitation Center at the Ribeirão
Preto General Hospital. After adequate explanations, those
who agreed to participate in the study signed the informed
consent form recommended by the institutional ethical review
board. We based sample size calculations on data from a single
study in the literature (11), which documented the effect
of TP treatment in this group of patients when compared to
the usual treatment, considering a type 1 error of 5% and a
type 2 error of 20%.
The inclusion criteria were as follows: either sex; older
than 18 years of age; spastic upper limb weakness due to
ischemic or hemorrhagic hemispheric stroke; and diagnosis
of PSSP, regardless of motor dominance
The exclusion criteria were as follows: previous shoulder
pain in the hemiplegic side of the body; pregnant or nursing
women; diagnosis of reflex sympathetic dystrophy; presence
of pain of central origin; cognitive impairment that impeded
assessment and collaboration with treatment; previous adverse
reactions to lidocaine; structured joint deformity in the pain-
ful shoulder; and uncontrolled coagulation condition.
Procedures: Evaluations occurred at the initial consulta-
tion, after one and three weeks and finally after 4 months.
The main outcomes were VAS ratings of pain intensity, which
ranged from 0 to 10 (12), and active and passive goniometry
of the shoulder for the movements of abduction and external
rotation in the sitting position (13). Additionally, subjects
and caregivers answered unstructured questions about the
difficulty and pain in performing daily life activities. When
the patients could not communicate adequately, the care-
givers were asked about it. The muscles that had been sys-
tematically examined for this study were the pectoralis
major, anterior, lateral and posterior divisions of the deltoid,
upper trapezius, supraspinatus, infraspinatus, teres major,
subscapularis, biceps brachii, triceps brachii, and brachior-
adialis, which were identified by superficial palpation
according to Travell’s guide of TP treatment. Ultrasound or
radiological guidance was not required. TP blocks with 1%
lidocaine required repetitive movements along the direction
of muscle fibers, according to the technique described by
Kraus H. (14,15). Needles for this procedure were usually
22G1’’ (25 x 0.7 mm) in the most superficial muscles;
however, 22G11/4’’ (30 x 0.7 mm) were also used for deeper
layers or more obese subjects. Needling was intended to elicit
the ‘twitch response’, which refers to the localized contrac-
tion of part of the muscle fibers that is visible to the naked
eye in the superficial muscles. In the deeper muscles, this
muscle response is not visible but may be noticed by a
movement of the needle for more experienced injectors, and
the patient may feel a sharp and subtle sensation that is
accompanied by a ‘jump sign’. The mean volume injected
was 8.0 ml, and for safety reasons, the maximal volume
was not more than 10.0 ml. The therapeutic sessions were
repeated for up to 3 consecutive weeks in those patients who
indicated pain levels above 5 in the VAS; however, even
without this pain level, the subjects were invited to return
for all the scheduled evaluations.
Statistical analysis: Qualitative variables were described as
percentages in each category, while the quantitative variables
were analyzed for normality by the Kolmogorov-Smirnov
test and described with adequate measures of central tendency
and dispersion. Missing values were imputed using the
last observation carried forward technique, and subjects’
data were evaluated according to an intention to treat
analysis. We used two-way repeated measures ANOVA to
test the group*time effect.
Outcomes: Patients who improved at least 4 points on the
VAS at any moment after the first TP block were classified
as ‘‘good responders’’, all others as ‘‘no response’’, and both
groups were analyzed separately with the same statistical
procedures. The significance level was 5%, with correction
for multiple comparisons.
’ RESULTS
We recruited 21 patients, of whom 18 fulfilled the inclusion
criteria: 13 (72%) were men, the mean age was 66.2±10.5 years
and the median time since the stroke was 9.0±6.8 months
(time since stroke: good responders: 13.7±11.8 x no response:
7.5±4.0, p=0.119). All patients had spasticity in the weakened
upper limb, classified as grade 2 or above on the modified
Ashworth scale, and 8 had hemiparesis on the right side
(Table 1). For 3 patients, only one TP block was performed
since there was complete abolition of pain. For 3 other sub-
jects, 2 TP blocks were necessary to achieve sufficient pain
relief. Eleven muscles were identified by palpatory surface
anatomy in the upper, anterior and posterior portions of the
shoulder and arm (Table 1). Myofascial treatment with TP block
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was most often performed in the subscapularis (30 times),
upper trapezius (29 times) and pectoralis major (27 times).
Table 2 shows an increase in the passive abduction of the
shoulder at the end of the first and third weeks, but not after
4 months; on the other hand, in the active abduction, the gains
were minimal and not significant throughout the study. For
external rotation, there was no significant change in active or
passive goniometry.
Regarding the pain assessments, the whole group of
patients experienced some relief in the period from the
baseline assessment to the end of the first week (VAS scores:
7.6±2.7 and 5.8±3.6 at baseline and after the first week,
respectively; po0.05) and through the end of the third week
(VAS scores: 7.6±2.7 and 5.2±3.5 at baseline and after the
third week, respectively; po0.05) but not at the end of
four months (VAS scores: 7.6±2.7 and 6.6±2.9 at baseline
and after the fourth month, respectively; p=0.11). Both good
responders and those with no response had similar pain
levels at baseline, but by the third week, pain levels were
significantly lower in the good responder group (VAS scores:
8.2±2.2 and 3.2±3.7 at baseline and after the third week,
respectively; po0.05) and remained so after 4 months (VAS
scores: 8.3±1.6 and 3.5±3.5 at baseline and after 4 months,
respectively; po0.05) (Figure 1). Figure 2 shows continuous
improvement of passive shoulder abduction in the good
responder group, but significant levels were only identified
by the end of the follow-up period at 4 months (goniometry:
71.9±22.6 and 107.6±38.2 at baseline and after 4 months,
respectively; po0.03). Five subjects were completely asymp-
tomatic with only 2 sessions of TP blocks.
’ DISCUSSION
The aim of the study was to evaluate the effects of PSSP
treatment by blocking TPs. In agreement with the clinical
experience of the researchers, it was possible to confirm the
hypothesis that this local inactivation of the TP attenuated
the PSSP indicated by improvements in the VAS mean values
in the first week after the procedure, with more pronounced
results in the third week, and maintenance of pain relief by
the end of 4 months. Additionally, when analyzing indivi-
dual cases, some patients maintained complete abolition
or very low pain values throughout the follow-up period.
We did not observe any side effects, such as drowsiness,
arrhythmia or hypotension, since the administered dose was
less than 0.1 g.
It may be argued that other causes of PSSP should have
been assessed. Shoulder subluxation is often associated with
shoulder pain in stroke survivors, but unless it is a clearly
flaccid extremity where the subacromial sulcus is evident,
and there is substantial relief with limb support, the litera-
ture fails to associate any radiological findings with PSSP.
Additionally, adhesive capsulitis is a diagnostic alternative
Table 2 - Frequency of identification of TP by muscles.
Muscle Number of blockades Percentage of blockades
Subscapularis 30 22%
Trapezius 29 21%
Pectoralis major 27 20%
Biceps brachii 11 10%
Supraspinatus 9 7%
Infraspinatus 9 7%
Triceps brachii 7 5%
Deltoid 7 5%
Large dorsal 4 3%
Brachioradialis 2 1.5%
Teres major 1 1%
TOTAL 136 100%
Table 1 - General characteristics of the subjects.
Complete
sample
Good
responders
No
response
n 18 9 9
Men (%) 13 6 7
Age (years) 66.2±10.5 67.4±7.9 64.9±13
Right-handed 16 7 9
Right hemiparesis 9 3 6
Number of blocks 2.65 2.4 2.9
Time since stroke
(months)
9.0±6.8 13.7±11.8 7.5±4.0
VAS initial 8.3±1.8 7.8±2.0 8.8±1.5
Figure 1 - Average pain intensity rating (VAS) of the shoulder over the course of treatment.
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that requires contrast arthrographic findings of a reduction
in capsular volume. This condition is clinically suspected
when the subject fails to either passively or actively abduct
the shoulder, sometimes because of pain. In the spastic
hemiplegic patient, failure to abduct the shoulder is usually
caused by an increased tone in the adductors, i.e., the pecto-
ralis major, subscapularis, teres major and latissimus dorsi,
but it must be stressed that the taut bands in a TP are also
associated with reduced range of motion (ROM), thus these
three conditions share this same symptomatology. The imp-
rovement in ROM in the good responder group in this sample
indicated that MPS rather than the other two conditions
should be considered, or at least be considered as one com-
ponent of the pain-related impairment.
The hypotheses of the pathophysiological mechanisms of
MPS involve the accumulation of extracellular material that
is not reabsorbed after the occurrence of micro- and macro-
muscle lesions (16), which results in a limitation of move-
ment and tissue adherence, causing pain, tension, and spasm
(17). Shortened and thickened sarcomeres are observed in
TPs, while in adjacent regions, the sarcomeres are thin and
slender. This generates tension at the TP and in these areas,
which can be perceptible in the connective tissues in neigh-
boring structures, causing contractile elements to fail and
release substances that sensitize the nociceptors.
Microlesions rupture the sarcoplasmic reticulum and pro-
mote the release and accumulation of Ca++ in the sarco-
plasm, which interacts with ATP, initiating the interaction of
actin and myosin and resulting in the segmental shortening
of the sarcomere, which explains the localized hypertonia
identified by palpable nodules within the muscle. The exac-
erbated contraction amplifies the energy consumption that
cannot be supplied by the local microcirculation due to the
mechanical compression of the capillaries. Consequently,
the region starts to work in ischemic conditions, depleting
the local ATP and further damaging the active Ca++ uptake.
In this way, TPs are associated with prolonged and exag-
gerated contraction of muscle fibers, causing muscle fatigue.
The sum of localized ischemia with extracellular abnormal-
ities and release of algiogenic substances is responsible for
the self-sustained vicious cycle of contraction-ischemia-
contraction that is responsible for central and peripheral
pain sensitization.
Nociceptors linked to nerve fibers III and IV are stimulated
and protrude into the posterior horn of the gray matter of the
spinal cord, then signals ascend via the rostral projection
tracts to supraspinal units. Painful stimuli induce several
secondary and CNS-sensitizing alterations contributing to
the clinical picture of MPS (18). Spinal cord neurons are
spontaneous because of their increased excitability. There-
fore, there is allodynia, represented by the increase in the
reaction to mechanical stimuli and hyperesthesia caused by
the increase in the receptive fields.
Some of the side effects described for TP inactivation with
lidocaine infiltration are arrhythmia and hypotension, which
are dose-dependent and were not expected to be present in
doses as low as those used in this study. Allergic reactions
were not observed either. None of the subjects presented
adverse events from the needling itself, such as bruises or
postprocedure soreness.
Support and proper movement of the shoulder joint depend
substantially on the harmony of muscle contraction, which
can be severely compromised by the change in strength and
tone in stroke individuals. All participants in this study had
spastic hemiparesis as the motor sequelae of the brain injury,
which may have triggered the onset of TPs due to muscle
imbalance and lack of regional harmonic coordination. Con-
sidering the reduction in abduction and external rotation in
both active and passive mobilization in the initial evaluation,
the suspected involved muscles preferentially fell on those
with an adductor role and internal rotation, that is, the
subscapular, teres major, major dorsal and major pectoral
muscles, which share very close insertions in the smaller
tubercle and intertubercular groove.
The treatment of MPS can be performed in several ways,
all based on the inactivation of TPs: among these treatment
modalities are manual inactivation, although there is no
evidence of its efficacy (19); nonmanual and noninvasive
techniques, among which electrical, mechanical and electro-
magnetic stimuli are included, for which there is no evidence
Figure 2 - Passive shoulder abduction goniometry based on the patient’s response to treatment.
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of their long-term benefits; and finally, the use of invasive
techniques, such as dry needling or lidocaine infiltration. The
effect of trigger point blockade in PSSP may be due to the
mechanical stimulation by the needle or the pharmacological
action of topical analgesics (lidocaine). Cummings and White
(20) reviewed 21 articles and concluded that the needling
efficacy in pain reduction was independent of the drug
injected. Hyuk Ga et al. (21) compared needling with acu-
puncture needles and needling with lidocaine injection and
concluded that both treatments were effective and that post-
treatment pain was the same in both groups. The systematic
review by Lee et al. (1) indicated acupuncture as an effective
treatment for PSSP. The most frequently described points
to be treated with dry needling are immediately below the
acromioclavicular joint or in the shoulder posterior wall,
either along the posterior axillary fold posterior to the gleno-
humeral joint or in the supra- and infraspinal regions, which
corresponded topographically to the muscles treated in this
study. The treatment effect, in addition to the reduction in pain,
was the improvement in sleep quality and a gain in ROM
that enabled some daily living activities to become easier,
such as dressing, hygiene, or even gait, as well as improve-
ments for caregivers while taking care of their patients. Con-
sequently, adherence to the rehabilitation program was more
appealing (2), and there were better functional prognoses (4).
Patients with better analgesic responses to treatment are
highlighted in Figures 1 and 2 to draw attention to this com-
ponent of PSSP, which can be easily evaluated in the office
and quickly treated with a simple and low-cost procedure
with very rewarding results. Statistical comparisons between
the subgroups failed to suggest any predictive feature of
treatment success. This study was limited by the sample size,
which may have reduced the statistical power to demon-
strate the results of this therapeutic intervention.
We succeeded in demonstrating the presence of MPS in as
many as half of the studied sample, and the proper inactiva-
tion of TPs resulted in a reduction in pain and an improve-
ment in ROM. This subgroup of patients with substantial
and prolonged therapeutic responses can motivate the clinician
to always consider MPS on the list of possible etiologic
diagnoses and to master this examination and therapeutic
technique, considering the impact that can be quickly obtained
to improve functioning, care and quality of life with very
little investment.
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